Elromo 25 Mg Tablets

Product Description

Elrom25mg Tablet is an anticoagulant drug belonging to the thrombopoietin (TPO) receptor agonist category, containing the active ingredient Eltrombopag. It treats low platelet counts caused by primary immune thrombocytopenia (ITP) or hepatitis C (HCV) infection. ITP refers to an autoimmune disorder in which the immune system destroys platelets. Platelets are blood cells that aid in clotting and protect blood vessel walls. When platelet levels are low, it can result in severe bleeding and bruising. This tablet is also used in adults to treat low blood counts caused by severe aplastic anaemia (a serious blood disease that occurs when the bone marrow fails to produce enough new blood cells).

This drug should not be used in individuals with known hypersensitivity or allergic reactions to the drug or its components. Allergic reactions can range from mild to severe and may include symptoms such as rash, itching, swelling, dizziness, or difficulty breathing. Elromo25mg Tablets are contraindicated in patients with severe liver impairment or active liver disease. This drug can potentially cause hepatotoxicity, as increased liver enzymes and bilirubin levels indicate. Using this drug in individuals with severe liver disease can further worsen liver function, so caution is advised. Your doctor will recommend that you are checked for cataracts. Your doctor should arrange regular testing if you do not have routine eye tests. You may also be checked for bleeding in or around your retina (the light-sensitive layer of cells at the back of the eye).

If you stop taking this tablet, your blood platelet count is likely to become low again within several days. The platelet count will be monitored, and your doctor will discuss appropriate precautions. A very high blood platelet count may increase the risk of blood clotting. However, blood clots can also form with normal or even low platelet counts. Your doctor will adjust your dose of this medicine to ensure that your platelet count does not become too high. Do not take this tablet with dairy products or drinks, as the calcium in these items affects the absorption of the medicine. Use effective birth control during the treatment, and if you become pregnant, you must inform your doctor. Elrom25mg Tablets are not advised for children under one with ITP. It is also not recommended for patients under 18 with low platelet counts caused by hepatitis C or severe aplastic anaemi Tell your doctor if you are taking, have recently taken, or might take other medicines. It includes medicines obtained without a prescription and vitamins.

Effective Platelet Aggregator for Chronic Conditions

Elromo 25 mg Tablets help manage low platelet counts in individuals with chronic immune thrombocytopenia, hepatitis C, or severe aplastic anemia. By stimulating platelet production, Elromo enhances the body's ability to prevent bleeding episodes and ensures better blood clotting capability for those at risk due to their condition.


Safety, Dosage, and Administration

Elromo must be taken by mouth as a once-daily tablet under medical supervision. Patients should follow their doctor's recommended dosage and duration. It is important to monitor liver function regularly, as the tablet may cause side effects such as headache, nausea, fatigue, and elevated liver enzymes.